Cart
sales@molnova.com
S-Dihydrodaidzein
CAS No. 879559-75-8
S-Dihydrodaidzein( (3S)-7-hydroxy-3-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one )
Catalog No. M26427 CAS No. 879559-75-8
S-Dihydrodaidzein is an enantiomer of dihydrodaidzein which is involved in equol biosynthesis in a lactic acid bacterium, Lactococcus sp. strain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 181 | In Stock |
|
| 5MG | 92 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameS-Dihydrodaidzein
-
NoteResearch use only, not for human use.
-
Brief DescriptionS-Dihydrodaidzein is an enantiomer of dihydrodaidzein which is involved in equol biosynthesis in a lactic acid bacterium, Lactococcus sp. strain.
-
DescriptionS-Dihydrodaidzein is an enantiomer of dihydrodaidzein which is involved in equol biosynthesis in a lactic acid bacterium, Lactococcus sp. strain.
-
In Vitro——
-
In Vivo——
-
Synonyms(3S)-7-hydroxy-3-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one
-
PathwayOthers
-
TargetOther Targets
-
RecptorCereblon
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number879559-75-8
-
Formula Weight256.257
-
Molecular FormulaC15H12O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOc1ccc(cc1)[C@H]1COc2cc(O)ccc2C1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kim K, et al. Disordered region of cereblon is required for efficient degradation by proteolysis-targeting chimera.Sci Rep. 2019 Dec 23;9(1):19654.
molnova catalog
related products
-
Tinnevellin glucosid...
Tinnevellin glucoside is a natural product from Cassia angustifolia.
-
AR-M 1000390 hydroch...
AR-M 1000390 (hydrochloride), also known as ARM-390, is a low-internalizing nonpeptidic δ-selective opioid receptor agonist; derivative of SNC 80.
-
WRW4
WRW4, a specific formyl peptide receptor-like 1 (FPRL1) antagonist, inhibits WKYMVm binding to FPRL1 with an IC50 of 0.23 μM. WRW4 specifically inhibits the increase in intracellular calcium by the FPRL1 agonists MMK-1, amyloid beta42 (Abeta42) peptide, and F peptide.
